Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/65740
Registo completo
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Brás, Susana Maria Pereira | por |
dc.contributor.author | França, Ângela Maria Oliveira Sousa | por |
dc.contributor.author | Cerca, Nuno | por |
dc.date.accessioned | 2020-06-23T13:10:19Z | - |
dc.date.available | 2020-06-23T13:10:19Z | - |
dc.date.issued | 2020-06-15 | - |
dc.identifier.citation | Brás, Susana; França, Angela; Cerca, Nuno, Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes. PeerJ, 8(e9295), 2020 | por |
dc.identifier.issn | 2167-8359 | por |
dc.identifier.uri | https://hdl.handle.net/1822/65740 | - |
dc.description.abstract | Human blood is often used as an ex vivo model to mimic the environment encountered by pathogens inside the host. A significant variety of experimental conditions has been reported. However, optimization strategies are often not described. This study aimed to evaluate key parameters that are expected to influence Staphylococcus epidermidis gene expression when using human blood ex vivo models. Our data confirmed that blood antimicrobial activity was dependent on initial bacterial concentration. Furthermore, blood degradation over time resulted in lower antimicrobial activity, with a 2% loss of leukocytes viability correlating with a 5-fold loss of antimicrobial activity against S. epidermidis. We further demonstrated that the volume of human blood could be reduced to as little as 0.18 mL without affecting the stability of gene expression of the tested genes. Overall, the data described herein highlight experimental parameters that should be considered when using a human blood ex vivo model for S. epidermidis gene expression analysis. | por |
dc.description.sponsorship | This work was supported by the Portuguese Foundation for Science and Technology (FCT) by the funded project PTDC/BIA-MOL/29553/2017, under the scope of COMPETE2020 [POCI-01-0145-FEDER-02955 and by the strategic funding of unit UIDB/04469/2020 and by European funds under BioTecNorte operation [NORTE-01-0145-FEDER-000004 funded by European Regional Development Fund under the scope of Norte2020. Susana Brás is supported by a fellowship granted by a Doctoral Advanced Training [Norte 69- 2015-15 funded by the European Social Fund under the scope of Norte2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript | por |
dc.language.iso | eng | por |
dc.publisher | Peerj, Inc. | por |
dc.rights | openAccess | por |
dc.subject | Bacterial survival | por |
dc.subject | Staphylococcus epidermidis | por |
dc.subject | Human blood ex vivo model | por |
dc.subject | Volume of human blood | por |
dc.subject | Gene expression | por |
dc.title | Optimizing a reliable ex vivo human blood model to analyze expression of Staphylococcus epidermidis genes | por |
dc.type | article | - |
dc.peerreviewed | yes | por |
dc.relation.publisherversion | https://peerj.com/ | por |
dc.comments | CEB53777 | por |
oaire.citationIssue | 6 | por |
oaire.citationVolume | 8 | por |
dc.date.updated | 2020-06-20T09:59:28Z | - |
dc.identifier.doi | 10.7717/peerj.9295 | por |
dc.description.publicationversion | info:eu-repo/semantics/publishedVersion | - |
dc.subject.wos | Science & Technology | por |
sdum.journal | PeerJ | por |
Aparece nas coleções: | CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
document_53777_1.pdf | 479,3 kB | Adobe PDF | Ver/Abrir |